Related Experiment Videos

Gentamicin dosage in children

Insights

Gentamicin dosing in children requires careful consideration. Doses of 1.7 mg/kg or less were inadequate; 2.5 mg/kg 8-hourly is suggested, with serum monitoring essential.

Area of Science:

  • Pediatric Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Gentamicin is a critical antibiotic for treating serious pediatric infections.
  • Optimizing gentamicin dosage in children is essential to ensure efficacy and minimize toxicity.
  • Pediatric pharmacokinetics of gentamicin can vary significantly with age and clinical status.

Purpose of the Study:

  • To evaluate the adequacy of serum gentamicin concentrations based on varying intramuscular doses in pediatric patients.
  • To establish evidence-based gentamicin dosing guidelines for children.
  • To highlight the importance of therapeutic drug monitoring for gentamicin therapy.

Main Methods:

  • Serum gentamicin levels were measured in 49 children aged 2 weeks to 11 years.
  • Patients received 8-hourly intramuscular gentamicin doses ranging from 0.7 mg/kg to 4.9 mg/kg.
  • Correlation between administered dose and achieved serum gentamicin concentration was analyzed.

Main Results:

  • Intramuscular gentamicin doses of 1.7 mg/kg or lower resulted in subtherapeutic serum concentrations.
  • Higher doses were required to achieve adequate gentamicin levels in the pediatric population.
  • Individual variability in serum concentrations necessitates dose adjustments.

Conclusions:

  • An 8-hourly intramuscular gentamicin dose of 2.5 mg/kg is proposed as a suitable starting point for most children without renal impairment.
  • Therapeutic drug monitoring of serum gentamicin levels is crucial for optimizing treatment and preventing toxicity.
  • Dose adjustments based on measured serum concentrations are necessary for effective gentamicin therapy in children.

Related Concept Videos